SCM
ALXN

Segantii Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Segantii Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-771,618
Closed -$142M – 672
2021
Q2 		$142M Buy
771,618
+342,804
+80% +$58.8M 4.41% 2
2021
Q1 		$65.6M Buy
428,814
+319,477
+292% +$49.4M 2.83% 5
2020
Q4 		$17.1M Buy
109,337
+73,187
+202% +$9.4M 0.89% 37
2020
Q3 		$4.14M Buy
36,150
+9,750
+37% +$1.05M 0.34% 35
2020
Q2 		$2.96M Buy
+26,400
New +$2.8M 0.22% 46

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return